4SC assets available for out-licensing

4SC is focused on developing targeted small molecule drugs with an epigenetic mode of action for the treatment of cancer. Other assets are available for partnering or out-licensing.

More information on these assets are available email hidden; JavaScript is required.

 

Share this page:

Follow us on: